Women's College Research Institute, Women's College Hospital, Breast Cancer Research, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management and Evaluation, Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Cancer Clinical Research Unit, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
JAMA Oncol. 2017 May 1;3(5):659-665. doi: 10.1001/jamaoncol.2017.0248.
Increasing numbers of women experience pregnancy around the time of, or after, a diagnosis of breast cancer. Understanding the effect of pregnancy on survival in women with breast cancer will help in the counseling and treatment of these women.
To compare the overall survival of women diagnosed with breast cancer during pregnancy or in the postpartum period with that of women who had breast cancer but did not become pregnant.
DESIGN, SETTING, AND PARTICIPANTS: This population-based, retrospective cohort study linked health administrative databases in Ontario, Canada, comprising 7553 women aged 20 to 45 years at the time of diagnosis with invasive breast cancer, from January 1, 2003, to December 31, 2014.
Any pregnancy in the period from 5 years before, until 5 years after, the index date of the diagnosis of breast cancer. Women were classified into the following 4 exposure groups: no pregnancy (the referent), pregnancy before breast cancer, pregnancy-associated breast cancer, and pregnancy following breast cancer.
Five-year actuarial survival rates for all exposure groups, age-adjusted and multivariable hazard ratios [HRs] of pregnancy for overall survival for all exposure groups, and time-dependent hazard ratios for women with pregnancy following breast cancer.
Among the 7553 women in the study (mean age at diagnosis, 39.1 years; median, 40 years; range, 20-44 years) the 5-year actuarial survival rate was 87.5% (95% CI, 86.5%-88.4%) for women with no pregnancy, 85.3% (95% CI, 82.8%-87.8%) for women with pregnancy before breast cancer (age-adjusted hazard ratio, 1.03; 95% CI, 0.85-1.27; P = .73), and 82.1% (95% CI, 78.3%-85.9%) for women with pregnancy-associated breast cancer (age-adjusted hazard ratio, 1.18; 95% CI, 0.91-1.53; P = .20). The 5-year actuarial survival rate was 96.7% (95% CI, 94.1%-99.3%) for women who had pregnancy 6 months or more after diagnosis of breast cancer, vs 87.5% (95% CI, 86.5%-88.4%) for women with no pregnancy) (age-adjusted HR, 0.22; 95% CI, 0.10-0.49; P < .001).
Pregnancy did not adversely affect survival in women with breast cancer. For breast cancer survivors who wish to conceive, the risk of death is lowest if pregnancy occurs 6 months or more after diagnosis.
越来越多的女性在诊断出乳腺癌前后或之后怀孕。了解妊娠对患有乳腺癌的女性生存的影响,将有助于对这些女性进行咨询和治疗。
比较诊断为乳腺癌时处于妊娠或产后期间的女性与未怀孕的乳腺癌女性的总生存率。
设计、环境和参与者:这项基于人群的回顾性队列研究将加拿大安大略省的健康行政数据库进行了关联,其中包括 7553 名年龄在 20 至 45 岁之间的女性,她们在 2003 年 1 月 1 日至 2014 年 12 月 31 日期间被诊断患有浸润性乳腺癌。
在诊断为乳腺癌之前的 5 年至之后的 5 年内的任何妊娠。女性被分为以下 4 个暴露组:无妊娠(参照组)、乳腺癌前妊娠、妊娠相关性乳腺癌和乳腺癌后妊娠。
所有暴露组的 5 年生存估计率、所有暴露组的年龄调整和多变量生存率的妊娠比值[HRs],以及乳腺癌后妊娠女性的时间依赖性 HRs。
在研究中的 7553 名女性中(平均年龄 39.1 岁;中位数 40 岁;范围 20-44 岁),无妊娠女性的 5 年生存估计率为 87.5%(95% CI,86.5%-88.4%),乳腺癌前妊娠女性为 85.3%(95% CI,82.8%-87.8%)(年龄调整的 HR,1.03;95% CI,0.85-1.27;P=0.73),妊娠相关性乳腺癌女性为 82.1%(95% CI,78.3%-85.9%)(年龄调整的 HR,1.18;95% CI,0.91-1.53;P=0.20)。诊断为乳腺癌后 6 个月或更长时间妊娠的女性 5 年生存估计率为 96.7%(95% CI,94.1%-99.3%),而无妊娠的女性为 87.5%(95% CI,86.5%-88.4%)(年龄调整的 HR,0.22;95% CI,0.10-0.49;P<0.001)。
妊娠并未对患有乳腺癌的女性的生存产生不利影响。对于希望怀孕的乳腺癌幸存者来说,如果怀孕发生在诊断后 6 个月或更长时间,死亡风险最低。